Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis

Journal of Clinical Pathology - Tập 64 Số 4 - Trang 354-357 - 2011
S Jabbar1, John Drury2, J N Fordham1, Harish K. Datta3, Roger M. Francis4, Stephen Tuck1
1Rheumatology Department, The James Cook University Hospital, Middlesbrough, UK
2Pathology Department, The James Cook University Hospital, Middlesbrough, UK
3Department of Clinical Biochemistry, Newcastle University, Newcastle upon Tyne, UK
4The Institute of Ageing and Health, Newcastle University, Campus of Ageing and Vitality, Newcastle upon Tyne

Tóm tắt

BackgroundOsteoprotegerin (OPG) and receptor activator of nuclear factor κ B ligand (RANKL) play a critical role in the regulation of bone turnover, but the relative importance of these two cytokines in the pathogenesis of postmenopausal osteoporosis is controversial.AimTo investigate the relationship between circulating levels of OPG, RANKL, bone turnover and bone mineral density (BMD) in postmenopausal women.MethodsA cross-sectional study of 185 women with osteoporosis and 185 age- and sex-matched control subjects was undertaken. Measurements were made of plasma OPG, RANKL, interleukin-6 (IL-6), sex steroids, calciotropic hormones, biochemical markers of bone turnover, BMD and anthropometry. Health questionnaires were administered.ResultsPlasma RANKL was significantly higher (p<0.0001) in women with osteoporosis (0.66±0.67 pmol/l) than in control subjects (0.37±0.38 pmol/l), as was plasma OPG (18.70±9.70 pmol/l in women with osteoporosis, 10.44±5.85 pmol/l in control subjects; p<0.0001). OPG/RANKL ratio was higher in women with osteoporosis (51.3) than in control subjects (36.6). The women with osteoporosis also had significantly higher biochemical markers of bone turnover, IL-6 and parathyroid hormone and lower 25-hydroxyvitamin D and oestradiol than the control subjects. Multiple regression analysis showed that lumbar spine and femoral neck BMD in postmenopausal women were best predicted by OPG and RANKL, giving an R2value of 15.5% and 14.9%, respectively.ConclusionsThis study indicates that the circulating levels of OPG and RANKL are inversely related to BMD and contribute to the development of osteoporosis in postmenopausal women.

Từ khóa


Tài liệu tham khảo

10.1016/0002-9343(93)90218-E

10.1016/S8756-3282(01)00614-7

10.1007/s11914-008-0027-3

10.1136/jech.2006.056622

Russell RG . Pathogenesis of Osteoporosis. In: Hochberg MC Silman AJ Smolen SJ , eds. Rheumatology. 3rd edn. New York: Mosby, 2003:2075–147.

10.1007/s00198-005-2039-5

10.1111/j.1469-1809.2005.00242.x

10.1007/s00108-008-2113-0

10.1136/jcp.2007.048868

Nakamura, 2009, Osteoclastogenesis and bone resorption, Nippon Rinsho, 67, 889

10.1016/j.maturitas.2008.04.005

10.1007/978-0-387-89520-8_9

Morabito, 2004, Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle, J Bone Miner Res, 19, 727, 10.1359/jbmr.040113

10.1007/s00198-005-1844-1

10.1007/s00223-004-0074-4

10.1007/s10195-005-0087-4

10.1530/EJE-06-0753

10.1159/000196280

10.1097/gme.0b013e3181a181b8

10.1007/s00223-004-0007-2

10.1111/j.1600-0765.2010.01317.x

10.1093/ije/23.2.359

Szulc, 2001, Osteoprotegerin plasma levels in men: correlation with age, estrogen and testosterone status, J Clin Endocrinol Metab, 86, 31625

10.1210/jc.86.2.631

10.1007/s00198-004-1699-x

Thông tin
Thông tin xuất bản

Journal of Clinical Pathology

Tập 64 Số 4

354-357

Thông tin tác giả